SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-046252
Filing Date
2024-05-23
Accepted
2024-05-23 16:00:10
Documents
14
Period of Report
2024-05-22
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0206791-8k_inmune.htm   iXBRL 8-K 35178
2 FIRST AMENDMENT TO THE BYLAWS OF INMUNE BIO INC ea020679101ex3-1_inmune.htm EX-3.1 4594
  Complete submission text file 0001213900-24-046252.txt   218289

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE inmb-20240522.xsd EX-101.SCH 3018
4 XBRL LABEL FILE inmb-20240522_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE inmb-20240522_pre.xml EX-101.PRE 22361
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0206791-8k_inmune_htm.xml XML 3914
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 24977982
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)